LP
Liminatus Pharma, Inc. Class A Common Stock
🇺🇸XNAS.LIMNUnited StatesHealthcare
$3.50USDdown -0.02 (-0.57%)OpenEnd of day5:08 PM
Price$3.50-0.02 (-0.57%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US53271X1081
- CUSIP
- Not reported
Company
- Employees
- 1
- Headquarters
- Cerritos, United States
- Website
- https://liminatuspharma.com
- CEO
- Mr. Chris Kim J.D., L.L.M.
Market
- Shares outstanding
- 1.3M
- Market cap
- $4.7M
Key dates
- Next earnings
- Oct 2, 2026
Highlights
- Market cap
- $4.7M
- EPS LTM
- -$26.36
- P/E LTM
- -0.00
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$12.52M-625.79%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$3.99M+59.52%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.